Furthermore, TOP2A was a recently identified target of anti-cancer drugs, such as Anthracyclines (approved for the treatment of breast cancer) and Etoposide (approved for treating small-cell lung cancer, ovarian and testicular, choriocarcinoma, lymphoma, and acute myeloid leukemia) 4, 21-25. The gene discussed is TOP2A; the disease is breast cancer.